Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-090745
Filing Date
2021-07-09
Accepted
2021-07-09 18:28:24
Documents
1
Period of Report
2021-07-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121908-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121908-5_4seq1.xml 4 4010
  Complete submission text file 0001104659-21-090745.txt   5524
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 360 HILLTOP RD PAOLI PA 19301
Business Address
McGroarty Jeffrey Brian (Reporting) CIK: 0001563273 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 211083873